AI is increasingly being used in clinical settings and has the potential to improve patient outcomes, but today’s payment models are limiting its adoption, according to a report released last
The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says
AI is playing an increasingly central role in patient care at hospitals across the country, but the same models driving that innovation are also being turned against providers by hackers.
The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints
Medical device companies and digital health founders that are developing and deploying healthcare artificial intelligence (AI) tools face a recurring product-design conflict. The strongest business case is usually an improving
Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain
The women’s oncology market is poised for significant growth, but persistent gaps in funding, innovation and patient access continue to hold back progress, according to a new PwC report. The
Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs
Statins are a standard drug for managing high cholesterol, but for patients who need something stronger, a newer class of medicines has become another option. In the more than a
Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges
Life sciences companies and investors continue to navigate a complex and challenging investment landscape – marked by high interest rates, a volatile regulatory environment, tight venture capital (VC) markets, and
Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition
Eli Lilly’s scope in neuroscience is broadening to psychedelics through a deal to buy AtaiBeckley, a clinical-stage company whose lead program might offer advantages over a blockbuster Johnson & Johnson
Why Settle for Acceptable Versus Optimal Outcomes?
Most foot, ankle and lower extremity surgeons have demonstrated success using off-the-shelf implants designed for generalized anatomy. However, as CT imaging, surgical planning software and 3D printed patient-matched implant creation
GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough
There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost its chance to become the first one. The drug, camlipixant,
The ‘Bot Vs. Bot’ Dynamic Between Providers & Payers Is Driving Up Costs for Everyone
The war between healthcare providers and payers has increasingly become a battle of algorithms, with AI tools for prior authorizations on one side and AI-powered appeals on the other. Ashis









